Impact of reduced vancomycin susceptibility on the therapeutic outcome of MRSA bloodstream infections
Open Access
- 30 October 2007
- journal article
- Published by Springer Nature in Annals of Clinical Microbiology and Antimicrobials
- Vol. 6 (1) , 13
- https://doi.org/10.1186/1476-0711-6-13
Abstract
The aim of this study was to determine whether clinical outcome of patients with methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia was correlated with vancomycin susceptibility of the corresponding strains.Keywords
This publication has 11 references indexed in Scilit:
- Epidemiology and Clinical Impact of Glycopeptide Resistance in Staphylococcus aureusInfection, 2004
- Relationship of MIC and Bactericidal Activity to Efficacy of Vancomycin for Treatment of Methicillin-Resistant Staphylococcus aureus BacteremiaJournal of Clinical Microbiology, 2004
- Treatment Outcomes for Serious Infections Caused by Methicillin‐ResistantStaphylococcus aureuswith Reduced Vancomycin SusceptibilityClinical Infectious Diseases, 2004
- Clinical Features Associated with Bacteremia Due to Heterogeneous Vancomycin‐IntermediateStaphylococcus aureusClinical Infectious Diseases, 2004
- Glycopeptide resistance in Staphylococcus aureus: is it a real threat?Journal of Infection and Chemotherapy, 2004
- Clinical Efficacy of Therapeutic Drug Monitoring in Patients Receiving VancomycinBiological & Pharmaceutical Bulletin, 2003
- Examination of Factors Affecting Efficacy and Adverse Effect, for the Retrospective Study of Vancomycin Hydrochloride (VCM)YAKUGAKU ZASSHI, 2001
- A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospitalJournal of Antimicrobial Chemotherapy, 2001
- Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycinThe Lancet, 1997
- ASA Physical Status ClassificationsAnesthesiology, 1978